Clinical Characteristics and Management of Patients with a Suspected COVID-19 Infection in Emergency Departments: A European Retrospective Multicenter Study.
COVID-19
dyspnea
emergencies
severe acute respiratory syndrome coronavirus 2 (SARSCoV-2)
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
19 Dec 2022
19 Dec 2022
Historique:
received:
29
09
2022
revised:
21
11
2022
accepted:
09
12
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
24
12
2022
Statut:
epublish
Résumé
Background: Our aim is to describe and compare the profile and outcome of patients attending the ED with a confirmed COVID-19 infection with patients with a suspected COVID-19 infection. Methods: We conducted a multicentric retrospective study including adults who were seen in 21 European emergency departments (ED) with suspected COVID-19 between 9 March and 8 April 2020. Patients with either a clinical suspicion of COVID-19 or confirmed COVID-19, detected using either a RT-PCR or a chest CT scan, formed the C+ group. Patients with non-confirmed COVID-19 (C− group) were defined as patients with a clinical presentation in the ED suggestive of COVID-19, but if tests were performed, they showed a negative RT-PCR and/or a negative chest CT scan. Results: A total of 7432 patients were included in the analysis: 1764 (23.7%) in the C+ group and 5668 (76.3%) in the C− group. The population was older (63.8 y.o. ±17.5 vs. 51.8 y.o. +/− 21.1, p < 0.01), with more males (54.6% vs. 46.1%, p < 0.01) in the C+ group. Patients in the C+ group had more chronic diseases. Half of the patients (n = 998, 56.6%) in the C+ group needed oxygen, compared to only 15% in the C− group (n = 877). Two-thirds of patients from the C+ group were hospitalized in ward (n = 1128, 63.9%), whereas two-thirds of patients in the C− group were discharged after their ED visit (n = 3883, 68.5%). Conclusion: Our study was the first in Europe to examine the emergency department’s perspective on the management of patients with a suspected COVID-19 infection. We showed an overall more critical clinical situation group of patients with a confirmed COVID-19 infection.
Identifiants
pubmed: 36556305
pii: jpm12122085
doi: 10.3390/jpm12122085
pmc: PMC9787691
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
N Engl J Med. 2020 Mar 26;382(13):1194-1196
pubmed: 32074416
J Belg Soc Radiol. 2021 Feb 16;105(1):9
pubmed: 33634237
Acad Emerg Med. 2020 Sep;27(9):811-820
pubmed: 32734624
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Euro Surveill. 2020 Nov;25(47):
pubmed: 33243355
Travel Med Infect Dis. 2020 Mar - Apr;34:101623
pubmed: 32179124
BMC Infect Dis. 2021 Jun 2;21(1):516
pubmed: 34078301
Intensive Care Med. 2020 Oct;46(10):1924-1926
pubmed: 32671470
Eur Radiol. 2021 Nov;31(11):8354-8363
pubmed: 33914118
J Med Internet Res. 2020 Oct 22;22(10):e20748
pubmed: 33006938
PLoS One. 2020 Aug 25;15(8):e0237302
pubmed: 32841294
Acad Emerg Med. 2020 Apr;27(4):309-311
pubmed: 32124506
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
AJR Am J Roentgenol. 2020 May;214(5):1072-1077
pubmed: 32125873
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Chest. 2020 Jul;158(1):106-116
pubmed: 32275978
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Chest. 2021 Oct;160(4):1222-1231
pubmed: 34004154
Cytokine Growth Factor Rev. 2020 Jun;53:38-42
pubmed: 32360420
Med Mal Infect. 2020 Jun;50(4):384
pubmed: 32240719
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
Radiology. 2021 Feb;298(2):E63-E69
pubmed: 32729811
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Radiology. 2021 Jan;298(1):E30-E37
pubmed: 32776832
Chin Med J (Engl). 2020 Jun 5;133(11):1261-1267
pubmed: 32209890
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Ann Emerg Med. 2020 Oct;76(4):405-412
pubmed: 32563600
Chest. 2020 Jul;158(1):97-105
pubmed: 32304772
Nature. 2020 Mar 13;:
pubmed: 32203355
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1430-1434
pubmed: 32267160
Eur Respir J. 2020 May 7;55(5):
pubmed: 32269088